drugset / Trial / NCT00939939
Effect of Sitagliptin on Postprandial Lipoprotein Metabolism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of the study is to evaluate whether sitagliptin can affect postprandial lipoprotein metabolism in type 2 diabetic patients.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glimepiride | Small molecule | 1 mg | — |
| Subject | Sitagliptin | Small molecule | 100 mg | — |